Table 1 Clinical and laboratory characteristics of the cohort by baseline CV risk score
CV risk score <10 | CV risk score ≥10 | p | |
|---|---|---|---|
Number | 897 | 761 | |
Age (years) | 52.0 ± 5.0 | 57.6 ± 4.8 | <0.001 |
Males (%) | 57.6 | 34.6 | <0.001 |
Living in a rural area (%) | 42.4 | 38.0 | 0.07 |
University (%) | 9.9 | 4.6 | |
Secondary school (%) | 21.3 | 13.9 | |
Primary school (%) | 68.8 | 81.5 | <0.001 |
Current smokers (%) | 14.3 | 35.1 | <0.001 |
METS (h/week)* | 22.2 ± 10.3 | 20.6 ± 10.4 | 0.002 |
BMI (kg/m2) | 25.8 ± 4.4 | 27.5 ± 4.7 | <0.001 |
Waist circumference (cm) | 89.4 ± 12.5 | 93.7 ± 13.2 | <0.001 |
Systolic blood pressure (mmHg) | 127.5 ± 13.0 | 141.0 ± 15.9 | <0.001 |
Diastolic blood pressure (mmHg) | 81.1 ± 8.6 | 85.9 ± 9.5 | <0.001 |
Fasting glucose (mg/dl) | 99.4 ± 16.7 | 111.4 ± 40.4 | <0.001 |
Fasting insulin (µU/ml)** | 8.1 ± 4.4 | 9.3 ± 5.4 | <0.001 |
Total cholesterol (mg/dl) | 203.9 ± 36.0 | 232.3 ± 40.3 | <0.001 |
HDL cholesterol (mg/dl) | 62.1 ± 14.2 | 58.4 ± 12.1 | <0.001 |
Triglycerides (mg/dl)** | 122.1 ± 69.8 | 159.4 ± 109.7 | <0.001 |
CRP (mg/l)** | 2.2 ± 5.0 | 3.2 ± 6.4 | <0.001 |
CV risk score | 6.3 ± 2.0 | 17.1 ± 7.3 | <0.001 |
CV diseases at baseline (%) | 0 | 12.0 | <0.001 |
Statin use (%) | 2.0 | 6.6 | <0.001 |
Aspirin use (%) | 1.0 | 10.5 | <0.001 |